Loading insider details...
Beta
Latest Form 4 (Jul 14, 2026): Grant/Award of 22,426 SERA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 14, 2026 | SERA PROGNOSTICS, INC. (SERA) | Grant/Award | 22,426 | n/a |
| Feb 4, 2026 | SERA PROGNOSTICS, INC. (SERA) | Other (see footnotes) | 30,920 | n/a |
| Jun 6, 2025 | SERA PROGNOSTICS, INC. (SERA) | Grant/Award | 15,596 | n/a |
| Jun 7, 2024 | SERA PROGNOSTICS, INC. (SERA) | Grant/Award | 7,117 | n/a |
| May 31, 2024 | Singular Genomics Systems, Inc. (OMIC) | Grant/Award | 74,000 | n/a |
| Dec 22, 2023 | Evofem Biosciences, Inc. (EVFM) | Sale | 10 | $6.21 |
| Jul 7, 2023 | SERA PROGNOSTICS, INC. (SERA) | Grant/Award | 63,265 | n/a |
| Jun 6, 2022 | SERA PROGNOSTICS, INC. (SERA) | Grant/Award | 149,675 | n/a |
| May 6, 2022 | Evofem Biosciences, Inc. (EVFM) | Grant/Award | 6,000 | n/a |
| Jun 21, 2021 | Evofem Biosciences, Inc. (EVFM) | Purchase | 10,000 | $11.7K |